Why Astragalus Extract Sourcing Is More Complex Than It Looks
Astragalus (Astragalus membranaceus) has been used in traditional Chinese medicine for centuries. The modern supplement industry values it for immune modulation. But the gap between "astragalus extract" on a quotation and a product that delivers consistent immune activity is wide.
Three active fractions exist in the root. Most suppliers only assay one. Buyers who do not specify which fraction they need — and at what level — receive products with different biological activity from batch to batch.
The Three Active Fractions
| Compound Class | Key Marker | Typical Content in Root | Primary Bioactivity | Assay Method |
|---|---|---|---|---|
| Saponins | Astragaloside IV | 0.1-0.5% | Immune modulation, anti-inflammatory, telomerase activation (in vitro) | HPLC (UV or ELSD) |
| Polysaccharides | Astragalus Polysaccharides (APS) | 5-15% in raw root; 30-70% in extract | Macrophage activation, NK cell enhancement, complement system stimulation | Phenol-sulfuric acid method |
| Flavonoids | Calycosin, formononetin | 0.1-0.5% | Antioxidant, weak estrogenic activity | HPLC |
Most Astragalus Extract on the market is standardized to astragaloside IV because it is the easiest compound to quantify by HPLC. But APS drives a substantial portion of the immune activity. A product with 10% astragaloside IV and low APS content is not the same as a product with 2% astragaloside IV and 60% APS — even though the first looks "stronger" on paper.
Mechanism of Action
1. TLR4/NF-κB pathway modulation. Astragaloside IV modulates TLR4/NF-κB signaling in macrophages and dendritic cells, reducing pro-inflammatory cytokine production (TNF-α, IL-6) without the uncontrolled inflammatory cascade seen with TLR4 agonists like LPS (Fu et al., 2014).
2. T-cell and NK cell enhancement. APS increases CD4+ and CD8+ T-cell counts and enhances NK cell cytotoxicity. Animal studies and limited human trials suggest benefit for elderly subjects and athletes under intense training. Specific trial designs and extract compositions vary widely.
3. Telomerase activation (in vitro). TA-65, a commercial astragalus-derived product, claimed telomerase activation based on astragaloside IV research. The in vitro data exist (de Jesus et al., 2011). The human clinical data showing lifespan extension do not. Supplement brands should not structure marketing claims around this mechanism without regulatory counsel review.
Clinical Evidence Summary
Respiratory Infection Prevention
Meta-analyses of RCTs in children suggest astragalus extract may reduce acute respiratory infection frequency by roughly 20-30% versus placebo. The effect appears larger in children with recurrent infections and when the extract is taken for 8+ weeks. Studies used varying extracts (astragaloside IV content not consistently reported), so the dose-response relationship is unclear.
Immune Function in Athletes
Studies in athletes under intense training report improved CD4+/CD8+ ratio, increased NK cell activity, and lower post-training cortisol with astragalus supplementation. The immune-suppressing effect of intense training appears partially offset. Extracts used in these studies were typically low-dose astragaloside IV (0.3% by UV) at 500 mg/day — not high-potency extracts.
Elderly Immune Support
Studies in elderly subjects using APS-rich extracts report increases in serum immunoglobulins (IgA, IgG, IgM) and improvements in T-cell subsets. Polysaccharide content may matter more than saponin content for this demographic.
Specifications: What the Numbers Mean
| Specification | Grade Code | What It Measures | Capacity | Best For |
|---|---|---|---|---|
| Astragaloside IV 20% | ASE102 | Astragaloside IV monomer at 20% by HPLC. Confirmed by retention time. | 2 ton/month | Mid-tier immune supplements. Cost-positioned products requiring verified astragaloside IV content. |
| Astragaloside 30% | ASE071 | Total astragalosides at 30% by HPLC. | 1 ton/month | Formulations balancing cost and potency. Entry-level standardized grade. |
| Astragaloside 50% Powder | ASE040 | Total astragalosides at 50% by HPLC, powder form. | 3 ton/month | High-volume immune products. Our highest-capacity grade. |
| Astragaloside IV 70% | ASE072 | Astragaloside IV monomer at 70% by HPLC. High-purity single compound. | 2 ton/month | Premium formulations and clinical trial materials where monomer purity matters. |
| Astragaloside 98% | ASE039 | Pure astragaloside by HPLC. Individual compound confirmed by retention time and peak area. | 2 ton/month | Research-grade applications. High-end formulations with strict monomer specificity. |
Sourcing issue: A quotation for "Astragalus Extract, 10% astragaloside IV" without the test method is ambiguous. 10% by UV and 10% by HPLC are different products. UV-overstated values are common because UV picks up all saponins, not just astragaloside IV. Request the method.
Practical notes: Astragalus Extract powder is hygroscopic. Store sealed with desiccant. Heat stable up to 80°C; prolonged exposure above 90°C degrades astragaloside IV. Water solubility: APS fraction is water-soluble; astragaloside IV is poorly water-soluble. For beverage applications, APS-focused extracts or emulsified astragaloside IV are required.
What to Check on a COA
| Parameter | Limit | Method | Purpose |
|---|---|---|---|
| Astragaloside IV | Per spec | HPLC (preferred) or UV | Confirm test method. HPLC required for 98% grade. |
| Astragalus Polysaccharides | Per spec | Phenol-sulfuric acid | Relevant for immune-focused extracts. Often omitted on COAs. |
| Lead (Pb) | < 3.0 ppm | ICP-MS / AAS | Soil contamination. |
| Arsenic (As) | < 2.0 ppm | ICP-MS / AAS | Growing region dependent. |
| Cadmium (Cd) | < 1.0 ppm | ICP-MS / AAS | Fertilizer source. |
| Aflatoxin B1 | < 5.0 μg/kg | ELISA or HPLC | Critical for astragalus — root crops carry higher mycotoxin risk than leaf/stem materials. |
| Total Plate Count | < 1,000 CFU/g | USP <61> | Microbial load. |
| Yeast & Mold | < 100 CFU/g | USP <61> | Storage conditions indicator. |
| E. coli / Salmonella | Absent in 10g | USP <62> | Pathogen screen. |
| Pesticide Residues | Per USP <561> or EP | GC-MS / LC-MS | Required for root-based extracts including Astragalus Extract, Polygonum Cuspidatum Extract, and Puerariae Extract. Often omitted on first-round COAs. |
| Residual Solvents | Per USP <467> | GC Headspace | Ethanol, methanol used in extraction. |
| Loss on Drying | < 5.0% | USP <731> | Moisture content. |
Two Red Flags Specific to Astragalus
1. Missing aflatoxin B1 data. Astragalus is a root crop grown in soil. Mycotoxin risk is higher than for aerial plant parts. A COA without aflatoxin testing is incomplete for this ingredient.
2. APS content omitted on polysaccharide-focused extracts. If the product is marketed for immune support, the polysaccharide fraction drives much of the activity. The COA should report APS content by phenol-sulfuric acid method. Its absence suggests the supplier does not test for it — or the content is lower than claimed.
Formulation Considerations
Astragalus extract pairs with other immune modulators. The most common combination in the market is astragalus + Shiitake Extract (mushroom polysaccharides). The mechanisms are complementary: astragaloside IV modulates TLR4/NF-κB signaling, while Shiitake Extract polysaccharides (lentinan) activate dendritic cells through different pathways. The combination produces broader immune coverage than either alone.
Other common pairings: astragalus + elderberry (antiviral + immune), astragalus + zinc (T-cell support + direct antiviral). Dose range for immune formulas: 200-500 mg/day of a 10% astragaloside IV extract, or 1,000-2,000 mg/day of a 0.3% extract. Higher-dose APS-focused products use 500-1,000 mg/day of APS 50%+ material.
Water solubility is a formulation constraint for astragaloside IV. For ready-to-drink beverages, APS-focused extracts are preferred. For capsules and tablets, standard astragaloside IV extracts work without special handling.
Stability and Regulatory Notes
Standard storage (cool, dry, sealed): <5% astragaloside IV degradation over 24 months. APS is more stable than saponins. Accelerated testing (40°C/75% RH, 6 months): <8% loss of astragaloside IV. Degradation rates are comparable to other heat-sensitive compounds such as epigallocatechin gallate in Green Tea Extract. Nitrogen-flushed packaging recommended for high-potency extracts.
US: Dietary supplement ingredient under DSHEA. Structure-function claims permitted with FDA disclaimer. EU: No authorized health claims for astragalus under Regulation 1924/2006. General wellness language used. Canada: NHP ingredient; claims require PLA approval. Australia: Listed complementary medicine under TGA. Verify claim compliance with regulatory counsel.
About Our Astragalus Extract
Justen Biotechnology supplies five standard grades of astragalus extract from Astragalus membranaceus (Fisch.) Bunge root: astragaloside IV 20% (ASE102), astragaloside 30% (ASE071), astragaloside 50% powder (ASE040), astragaloside IV 70% (ASE072), and astragaloside 98% (ASE039). All grades are assayed by HPLC. Monthly production capacity ranges from 1 ton (ASE071) to 3 tons (ASE040). Minimum order quantity: 1 kg. Standard packaging: 25 kg/drum. Shipping by ocean or air.
Certifications: KOSHER, HALAL, NON-GMO. Full COA per batch: astragaloside IV assay, APS content, heavy metals, aflatoxin B1, pesticides, residual solvents, microbiology. GMP-certified facility. In-house HPLC and UV lab. Virtual or on-site audits available. Other immune ingredients in our catalog include Shiitake Extract, Vine Tea Extract, and Flaxseed Extract.
How can I request a sample of astragalus extract for evaluation?
Contact our team through the inquiry form or email. Evaluation samples (50-100 g) ship with corresponding COA. 25 kg trial quantities available for pilot production. Request a sample here.